drugset

drugset / Trial / NCT06296966

A Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye

NCT06296966 ↗

Phase 2 Unknown 40 enrolled Vanda Pharmaceuticals

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine the safety and efficacy of VSJ-110 compared to placebo in the treatment of dry eye.

Timeline

Start: 2024-02-29
Primary completion: 2024-07
Completion: 2024-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	VSJ-110	Unknown	—	—

Indications